(Q39638015)

13 September 2017

1 reference

title

Estrogen replacement therapy: current recommendations (English)

1 reference

13 September 2017

E G Lufkin

1

1 reference

13 September 2017

P C Carpenter

2

1 reference

13 September 2017

S J Ory

3

1 reference

13 September 2017

G D Malkasian

4

1 reference

13 September 2017

J H Edmonson

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 May 1988

1 reference

13 September 2017

1 reference

13 September 2017

volume

63

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

453-460

1 reference

POSTMENOPAUSAL OSTEOPOROSIS

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Prolonged estrogen therapy in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Prevention of spinal osteoporosis in oophorectomised women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Long-term estrogen replacement therapy prevents bone loss and fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Relative contributions of aging and estrogen deficiency to postmenopausal bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Conjugated Estrogens in the Treatment of Postmenopausal Women with Hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Menopausal estrogen therapy and hip fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Osteoporosis reexamined: complexity of bone biology is a challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Should perimenopausal women be screened for osteoporosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Involutional osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

A prospective study of postmenopausal estrogen therapy and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

The menopause: benefits and risks of estrogen-progestogen replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Estrogen replacement therapy: indications and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Estrogens and Endometrial Cancer in a Retirement Community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Thrombosis with low-estrogen oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

Biologic effects of transdermal estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965642-0

10.1016/S0025-6196(12)65642-0

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference